HEAR FROM PEERS

Peer-to-peer learning hub

Play Video

Improving Interstitial Lung Disease Diagnosis in a Multidisciplinary Discussion (MDD) Team Incorporating a Genomic Classifier

Listen to ILD experts provide an overview of their MDD and how the Envisia Genomic Classifier can be integrated into the ILD diagnostic algorithm. This ATS industry innovations webinar recording also includes a review and discussion of 3 real world cases in which the genomic classifier test impacted decision making.

Play Video

72 year old active male with exertional dyspnea

Hear ILD pulmonologist experts discuss the diagnostic workup for this patient including how the Envisia Genomic Classifier impacted clinical decision making.

Play Video

80 year old male with progressive shortness of breath

Hear ILD pulmonologist experts discuss the diagnostic workup for this patient including how the Envisia Genomic Classifier impacted clinical decision making.

Play Video

61 year old female with worsening lung function

Hear ILD pulmonologist experts discuss the diagnostic workup for this patient including how the Envisia Genomic Classifier impacted clinical decision making.

Case Studies & Presentations

Envisia resource library

Watch case studies and testimonials from physicians or on-demand videos about Envisia and its clinical utility.

Video Thumbnail
Play button

Envisia Physician Testimonial

Hear from Dr. Nina Maouelainin how she integrated Envisia Genomic Classifier into her clinical practice and the test’s impact on patient management.

Detects genomic UIP pattern to improve ILD diagnostic confidence

Usual interstitial pneumonia (UIP) is a critical factor in differentiating idiopathic pulmonary fibrosis (IPF) from other interstitial lung diseases (ILDs). The Envisia classifier improves ILD diagnostic and prognostic confidence, and can identify twice as many UIP patients than radiology alone when combined with HRCT.